Real-World Effectiveness Outcomes in Patients Diagnosed With Metastatic Triple-Negative Breast Cancer
Last Updated: Thursday, September 8, 2022
This study looked at treatment received and advancement of disease through death among patients with metastatic triple-negative breast cancer (mTNBC) from US community cancer centers from 2010 to 2016. More than 15 in 100 women with mTNBC were not treated, showing the need for more treatment choices. The usual course of mTNBC remains poor, which highlights the opportunity for newer therapies to improve outcomes.
Advertisement
News & Literature Highlights